AI in ICCVS for Science and Business

The International Centre for Cancer Vaccine Science (ICCVS), Team Leader of Clinical Peptidomics Group, dr Sachin Kote, has recently represented ICCVS at the AI for Science conference held on 20-21 March 2025 in Krakow, Poland. The conference organized by the Ministry of Science and Higher Education and Academic Computer Centre CYFRONET AGH under the Polish presidency of the Council of the European Union. The AI for Science conference was gathered to learn about real-world artificial intelligence (AI) applications across various scientific fields and to debate the future of AI and its role in academic and business ecosystems. The AI factory constructions, investment, and fundamental infrastructure for future AI development in Europe have been discussed, and more light has been shed on how artificial intelligence is transforming research and business processes.

ICCVS has mass spectrometers as state-of-the-art analytical instruments, and the clinical peptidomics group has several innovative methods that include immunopeptidomics, neo-antigen discovery and tissue extracellular peptidomics, serum peptidomics from both human and non-human biofluids, intracellular peptidomics, and routine quantitative proteomics research dedicated to enhancing health, environment, and safety. These novel methods generate the highest quality data; therefore, these data serve as a gold mine for AI-based applications and their implementation for discoveries and therapies. In addition, AI should be implemented to accelerate the NSCLC immunotherapy development; hence, ICCVS plays a dual role in AI for science and businesses, said dr Sachin Kote.

dr Sachin Kote